Abstract: Chapter 25 Management of Obesity: Pharmacotherapy Richard L. Atkinson, Richard L. AtkinsonSearch for more papers by this author Richard L. Atkinson, Richard L. AtkinsonSearch for more papers by this author Book Editor(s):Peter G. Kopelman, Peter G. Kopelman Professor of Clinical Medicine, Vice-Principal, Barts and The London, Queen Mary's School of Medicine and Dentistry, London, UKSearch for more papers by this authorIan D. Caterson, Ian D. Caterson Boden Professor of Human Nutrition, Human Nutrition Unit, University of Sydney, Sydney, NSW, AustraliaSearch for more papers by this authorWilliam H. Dietz, William H. Dietz Director, Division of Nutrition and Physical Activity, Centers for Disease Control and Prevention, Atlanta, GA, USASearch for more papers by this author First published: 01 July 2005 https://doi.org/10.1002/9780470987087.ch25Citations: 3 AboutPDFPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShareShare a linkShare onFacebookTwitterLinked InRedditWechat Summary This chapter contains sections titled: Introduction Rationale for use of obesity drugs Indications and contraindications for obesity drugs Drugs available at present for obesity Adrenergic drugs Serotonergic drugs Combined adrenergic-serotonergic drug Peripherally acting malabsorptive agent Non-approved drugs with potential for treating obesity Over-the-counter diet supplements, herbs and other agents Agents with potential for treating obesity Rimonabart Combinations of drugs for obesity, Phenylpropanolamine- benzocaine Phentermine-fenfluramine combination Fenfluramine-fluoxetine combination Phentermine-fluoxetine combination Sibutramine-orlistat Phentermine-orlistat Practical aspects of drug therapy Summary and conclusions Citing Literature Clinical Obesity in Adults and Children, Second Edition RelatedInformation
Publication Year: 2005
Publication Date: 2005-07-01
Language: en
Type: other
Indexed In: ['crossref']
Access and Citation
Cited By Count: 5
AI Researcher Chatbot
Get quick answers to your questions about the article from our AI researcher chatbot